Cargando…
Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102308/ https://www.ncbi.nlm.nih.gov/pubmed/30155270 http://dx.doi.org/10.1038/s41514-018-0027-1 |
_version_ | 1783349133080264704 |
---|---|
author | Dellinger, Ryan W. Santos, Santiago Roel Morris, Mark Evans, Mal Alminana, Dan Guarente, Leonard Marcotulli, Eric |
author_facet | Dellinger, Ryan W. Santos, Santiago Roel Morris, Mark Evans, Mal Alminana, Dan Guarente, Leonard Marcotulli, Eric |
author_sort | Dellinger, Ryan W. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6102308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61023082018-08-28 Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study Dellinger, Ryan W. Santos, Santiago Roel Morris, Mark Evans, Mal Alminana, Dan Guarente, Leonard Marcotulli, Eric NPJ Aging Mech Dis Author Correction Nature Publishing Group UK 2018-08-20 /pmc/articles/PMC6102308/ /pubmed/30155270 http://dx.doi.org/10.1038/s41514-018-0027-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Author Correction Dellinger, Ryan W. Santos, Santiago Roel Morris, Mark Evans, Mal Alminana, Dan Guarente, Leonard Marcotulli, Eric Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study |
title | Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study |
title_full | Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study |
title_fullStr | Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study |
title_full_unstemmed | Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study |
title_short | Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study |
title_sort | author correction: repeat dose nrpt (nicotinamide riboside and pterostilbene) increases nad(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102308/ https://www.ncbi.nlm.nih.gov/pubmed/30155270 http://dx.doi.org/10.1038/s41514-018-0027-1 |
work_keys_str_mv | AT dellingerryanw authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT santossantiagoroel authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT morrismark authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT evansmal authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT alminanadan authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT guarenteleonard authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT marcotullieric authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy |